RUNX1 and prostate cancer: Thus, we revealed a significant role of RUNX1 in androgen-dependent and androgen-independent cancer growth and demonstrated that RUNX1 loss could be a diagnostic tool for advanced prostate cancer as modeled in Fig.6G.